)
Else Nutrition (BABY) investor relations material
Else Nutrition Investor Summit Virtual Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic positioning and product innovation
Introduced the first whole plant-based, dairy- and soy-free early life nutrition range using almonds and buckwheat, targeting a significant portion of the $100 billion global infant nutrition market.
Products offer improved health benefits, reduced allergen risk, and are modeled to meet human milk nutritional standards, supported by a scientific advisory board and proprietary technology.
Achieved over 60% lower carbon footprint compared to dairy products and are Clean Label certified, appealing to health- and environmentally-conscious consumers.
Product line includes baby cereals, toddler and kids nutrition, and expansion into adult nutrition, with strong distribution partnerships in North America and revived direct-to-retail sales in Canada.
Financial turnaround and operational highlights
Achieved significant margin and cost improvements in 2025, with a plan to reach profitability by early 2027.
Improved Q3 gross margins to 34% through cost reduction and supply chain efficiencies, and reduced operational expenses by nearly 70% year-over-year.
Cash burn reduced from $1.15 million to under $200,000, now at approximately $50,000, supporting financial sustainability.
Maintained stable revenue despite marketing and inventory constraints, with strong demand for unique products.
Secured funding to support operations until reaching cash flow positivity.
Regulatory and industry landscape
U.S. infant nutrition market has faced outdated FDA regulations, allergen risks, contamination incidents, and supply shortages, highlighting the need for innovation.
Operation Stork Speed launched by the U.S. government to modernize regulations, increase contaminant testing, and support new formula innovation.
NASEM recommended modernizing protein evaluation methods, enabling fair assessment of plant-based proteins.
Legislative breakthrough in November 2025 directed the FDA to streamline approval for non-dairy, non-soy formulas.
- Gross margin jumped to 25% as cost cuts offset flat sales and U.S. retail expanded.BABY
Q1 202523 Nov 2025 - Gross margin reached 34% and costs fell, paving the way to break-even by late 2026.BABY
Q3 202518 Nov 2025 - Revenue fell 14.8% in 2024, but cost cuts and new launches aim to drive 2025 growth.BABY
Q4 202410 Nov 2025 - Revenue fell on inventory issues, but cost cuts halved losses and margin recovery is expected.BABY
Q2 202516 Sep 2025 - Liquidity challenges persist as losses continue and going concern risk remains high.BABY
Q3 202413 Jun 2025 - Net loss narrowed and gross margin improved, but going concern risk persists amid cash constraints.BABY
Q2 202413 Jun 2025
Next Else Nutrition earnings date
Next Else Nutrition earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)